Haemophilia: Medical Treatments

Department of Health and Social Care written question – answered on 6th November 2018.

Alert me about debates like this

Photo of Jim Shannon Jim Shannon Shadow DUP Spokesperson (Human Rights), Shadow DUP Spokesperson (Health)

To ask the Secretary of State for Health and Social Care, how many people who were in receipt of (a) factor VIII and (b) factor IX Extended Half Life (EHLs) products had that treatment removed for (i) clinical and (ii) non-clinical reasons in 2017-18.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

NHS England does not collect or hold information on the number of patients who have switched from Factor VIII and Factor IX Extended Half Life products to other treatments for clinical or non-clinical reasons in 2017-18.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.